PALATIN TECHNOLOGIES, INC. Class of Warrant or Right, Outstanding
PALATIN TECHNOLOGIES, INC. (PTN) had Class of Warrant or Right, Outstanding of 6.01 thousand shares as of 2025-11-17, per its 10-Q filed 2026-05-13.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-05-13
- 2025-11-17: Class of Warrant or Right, Outstanding 6.01K shares.
- 2013-06-30: Class of Warrant or Right, Outstanding 91.95M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2025-11-17 | 6.01K shares 10-Q · filed 2026-05-13 |
| 2013-06-30 | 91.95M shares 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |